614 related articles for article (PubMed ID: 7756983)
41. High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen.
Ni F; Konishi Y; Bullock LD; Rivetna MN; Scheraga HA
Biochemistry; 1989 Apr; 28(7):3106-19. PubMed ID: 2742828
[TBL] [Abstract][Full Text] [Related]
42. High-resolution NMR studies of fibrinogen-like peptides in solution: structure of a thrombin-bound peptide corresponding to residues 7-16 of the A alpha chain of human fibrinogen.
Ni F; Meinwald YC; Vásquez M; Scheraga HA
Biochemistry; 1989 Apr; 28(7):3094-105. PubMed ID: 2742827
[TBL] [Abstract][Full Text] [Related]
43. Crystal structures of thrombin with thiazole-containing inhibitors: probes of the S1' binding site.
Matthews JH; Krishnan R; Costanzo MJ; Maryanoff BE; Tulinsky A
Biophys J; 1996 Nov; 71(5):2830-9. PubMed ID: 8913620
[TBL] [Abstract][Full Text] [Related]
44. Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes.
Mathews II; Padmanabhan KP; Ganesh V; Tulinsky A; Ishii M; Chen J; Turck CW; Coughlin SR; Fenton JW
Biochemistry; 1994 Mar; 33(11):3266-79. PubMed ID: 8136362
[TBL] [Abstract][Full Text] [Related]
45. Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-keto-amide transition-state mimetic.
Krishnan R; Tulinsky A; Vlasuk GP; Pearson D; Vallar P; Bergum P; Brunck TK; Ripka WC
Protein Sci; 1996 Mar; 5(3):422-33. PubMed ID: 8868478
[TBL] [Abstract][Full Text] [Related]
46. The methyl group of N(alpha)(Me)Arg-containing peptides disturbs the active-site geometry of thrombin, impairing efficient cleavage.
Friedrich R; Steinmetzer T; Huber R; Stürzebecher J; Bode W
J Mol Biol; 2002 Mar; 316(4):869-74. PubMed ID: 11884127
[TBL] [Abstract][Full Text] [Related]
47. The molecular environment of the Na+ binding site of thrombin.
Zhang E; Tulinsky A
Biophys Chem; 1997 Jan; 63(2-3):185-200. PubMed ID: 9108691
[TBL] [Abstract][Full Text] [Related]
48. Fibrinogen substrate recognition by staphylocoagulase.(pro)thrombin complexes.
Panizzi P; Friedrich R; Fuentes-Prior P; Richter K; Bock PE; Bode W
J Biol Chem; 2006 Jan; 281(2):1179-87. PubMed ID: 16230339
[TBL] [Abstract][Full Text] [Related]
49. Importance of the Arg-Gly-Asp triplet in human thrombin for maintenance of structure and function.
Gan ZR; Li Y; Connolly TM; Sardana MK; Tsai PK; Lewis SD; Shafer JA
Arch Biochem Biophys; 1993 Mar; 301(2):228-36. PubMed ID: 8384827
[TBL] [Abstract][Full Text] [Related]
50. Regions remote from the site of cleavage determine macromolecular substrate recognition by the prothrombinase complex.
Betz A; Krishnaswamy S
J Biol Chem; 1998 Apr; 273(17):10709-18. PubMed ID: 9553135
[TBL] [Abstract][Full Text] [Related]
51. Identification and characterization of the thrombin binding sites on fibrin.
Meh DA; Siebenlist KR; Mosesson MW
J Biol Chem; 1996 Sep; 271(38):23121-5. PubMed ID: 8798504
[TBL] [Abstract][Full Text] [Related]
52. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
53. Crystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4.
Bah A; Chen Z; Bush-Pelc LA; Mathews FS; Di Cera E
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11603-8. PubMed ID: 17606903
[TBL] [Abstract][Full Text] [Related]
54. Neutron and X-ray crystallographic analysis of the human α-thrombin-bivalirudin complex at pD 5.0: protonation states and hydration structure of the enzyme-product complex.
Yamada T; Kurihara K; Ohnishi Y; Tamada T; Tomoyori K; Masumi K; Tanaka I; Kuroki R; Niimura N
Biochim Biophys Acta; 2013 Aug; 1834(8):1532-8. PubMed ID: 23712263
[TBL] [Abstract][Full Text] [Related]
55. Probing the hirudin-thrombin interaction by incorporation of noncoded amino acids and molecular dynamics simulation.
De Filippis V; Colombo G; Russo I; Spadari B; Fontana A
Biochemistry; 2002 Nov; 41(46):13556-69. PubMed ID: 12427016
[TBL] [Abstract][Full Text] [Related]
56. Ligand binding to anion-binding exosites regulates conformational properties of thrombin.
Malovichko MV; Sabo TM; Maurer MC
J Biol Chem; 2013 Mar; 288(12):8667-8678. PubMed ID: 23378535
[TBL] [Abstract][Full Text] [Related]
57. Structure-activity relationships of recombinant hirudins.
Stürzebecher J; Walsmann P
Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
[TBL] [Abstract][Full Text] [Related]
58. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. I. Specificity of thrombin labeling.
Bock PE
J Biol Chem; 1992 Jul; 267(21):14963-73. PubMed ID: 1634535
[TBL] [Abstract][Full Text] [Related]
59. Substitution of Gly-548 to Ala in the substrate binding pocket of prothrombin Perijá leads to the loss of thrombin proteolytic activity.
Sekine O; Sugo T; Ebisawa K; Umeyama H; Iwahana H; Ruiz-Sáez A; de Bosch N; Matsudai M
Thromb Haemost; 2002 Feb; 87(2):282-7. PubMed ID: 11858488
[TBL] [Abstract][Full Text] [Related]
60. Thrombin-bound conformation of the C-terminal fragments of hirudin determined by transferred nuclear Overhauser effects.
Ni F; Konishi Y; Scheraga HA
Biochemistry; 1990 May; 29(18):4479-89. PubMed ID: 2350549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
